Hematological profile of patients with COVID-19 at Oran University Hospital in Algeria
Authors/Creators
- 1. Service d'hémobiologie et banque de sang CHU Oran
- 2. Service d'hématologie CHU Oran
Description
Introduction: COVID-19 is a viral zoonosis caused by the coronavirus strain SARS-CoV-2. Due to the rapid spread of this emerging infectious disease, the WHO has qualified it as an international pandemic. The objective of our study is to describe the haematological characteristics of patients with COVID-19 hospitalised at the CHU of Oran in Algeria. Patients and methods: This is a prospective study carried out between July 1st and October 15th, 2020, which included patients hospitalised and/or followed up in COVID-19 units of the CHU Oran in Algeria. The blood count was done on a Mindray BC - 6800 machine. Results: Our study included 68 patients of which 67.2% were male and 32.8% female (sex ratio M/F = 2) with a median age of 65 years. Check-ups revealed anaemia in 38.2% of patients. Hyperleukocytosis (62.2%), hyperneutrophilia (72.1%), lymphopenia (66.2%) , Eosinopenia (58.8%), monocytopenia (08.8%), monocytosis (20.6%), thrombocytosis (14.7%), high PMV (Mean Platelet Volume) in 27.9% of cases and high PPI (Platelet Distribution Index) in all patients. It is also noted that 85% of patients over 50 years of age have an NLR ≥ 3.13. Conclusion: Some parameters such as lymphopenia and eosinopenia have an important diagnostic value, while other parameters such as NLR (Neutrophils-to-lymphocyte ratio), MLR (Monocyte -to-lymphocyte ratio) and PLR (Platelet-to-lymphocyte ratio) offer a very valuable prognostic value.